Porto, March 1, 2021 – Focused on early-stage tech-based start-ups in the areas of ICT, Lifesciences, Industry 5.0 and Food tech, the Management Team of the Fund recognized at WeNou promising characteristics that motivated its first investment, just 60 days after its inception: an innovative technology, a highly motivated and skilled team, and market traction with potential to scale-up.
WeNou provides innovative services based on DNA analysis, especially focused on Next Generation Sequencing (NGS) technology, starting with applications for the food industry, where the supply chain stakeholders show increasingly concerns about food authenticity, safety, and quality, while consumers are demanding more accurate information about the products.
With this investment, WeNou will be able to accelerate its growth by attracting new customers while keep on using their core expertise on NGS for refining the application of this technology to solve the growing challenges of its customers.
“WeNou is disrupting food supply chains with cutting-edge technology and we are confident that Sandra and her team have the right capabilities to grow WeNou into a world-class leading player in this sector”, said Roberto Branco, Founder and CEO of Beta Capital.
Sandra Chaves, Founder and CEO of WeNou, highlighted that “The investment now made by Beta Capital will be of most importance to increase our R&D activities, to offer new solutions, reaching new markets and growing as a main leader for innovation on molecular biology-based methods.”
About Beta Capital
Beta Capital is one of the oldest independent and private VC firms in Portugal, operating since 2003. Focused on supporting innovative tech ventures to unlock its potential by providing smart funding and hands-on advisory, Beta Capital’s team has an entrepreneurial track record and thorough experience in the VC industry, financing innovative businesses. Beta Capital cares about the planet, the Humankind and its stakeholders according to the Principles of Responsible Investment.
WeNou is an independent company based in Lisbon and created in May 2019, joining an experienced team with strong scientific, technical, market and commercial knowledge. Its activities are highly focused on developing new molecular biology solutions for the industry. WeNou provides innovative services based on DNA analysis, specially focused on Next Generation Sequencing (NGS) technology and has ISO 17025 Accreditation.